Aescap
  • Home
  • About us
    • The Team
    • Strategy
    • Sustainability
    • Careers
  • Funds
    • Aescap Funds
    • Performance
    • Fund structure
    • Fund management
    • Fund setup
  • Biotech
    • High growth
    • Takeover premiums
    • Specialized market
  • Invest
    • How to invest
    • NextGen
    • Documents
  • Contact
    • Information meetings
  • Login
  • Nederlands
  • English

Fund structure

Fund structure09.17.2021
  • Aescap Life Sciences
  • Aescap Genetics
  • Performance
  • Fund structure
  • Fund management
  • Fund setup
  • Attend our meetings

News

  • Aescap Genetics Newsletter Q1 2022 April 12, 2022
  • Aescap Life Sciences Newsletter Q1 2022 April 12, 2022
  • Aescap Life Sciences Quarterly Update Q4 2021 January 7, 2022
Aescap
Barbara Strozzilaan 101, 1083 HN Amsterdam, Nederland
Tel. + 31 20 570 29 40 E-mail: service@aescap.com
Alle rechten voorbehouden. © 2022

Do not run any unnecessary risk. Read the Key Information Document and the Key Investor Information Document of the Funds. This communication is neither an offer to sell nor a solicitation to invest. Past performance is not indicative of future results. The value of investments and any income generated may go down as well as up and is not guaranteed. Privium Fund Management B.V. (Privium) is authorized and regulated by the Dutch Authority for the Financial Markets (www.afm.nl) as an Alternative Investment Fund Manager (AIFM). The Funds and its manager, Privium Fund Management B.V., are held in the register of Dutch Authority for the Financial Markets. The Prospectus of the Funds, the Key Information Documents and the Key Investor Information Documents can be downloaded via the website of the Funds (www.aescap.com) and the Fund Manager (www.priviumfund.com). The performance overviews shown in this communication have been carefully composed by Privium Fund Management B.V. No rights can be derived from this communication.

​